C12Y 501/99006
Nadh-hydrate epimerase
Official title: NAD(P)H-hydrate epimerase (5.1.99.6)
C12Y501/99006 (Nadh-hydrate epimerase) appears on 2 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 3
- Assignees
- 1
- Inventors
- 3
- Latest grant
- 25 Oct 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- Compositions and methods for treating or ameliorating neuroinflammation, neurodegeneration, neuropathic pain, and migraine25 Oct 2022US 11,478,556 B2The Regents of the University of California
- Compositions and methods for treating or ameliorating neuroinflammation, neurodegeneration, neuropathic pain, and migraine4 Aug 2020US 10,729,788 B2The Regents of the University of California
- Compositions and methods for targeting inflammatory or activated cells and treating or ameliorating inflammatory conditions and pain27 Jun 2024US 2024/0209341 A1The Regents of the University of California
- Compositions and methods for treating or ameliorating neuroinflammation, neurodegeneration, neuropathic pain, and migraine17 Dec 2020US 2020/0390906 A1The Regents of the University of California
- Compositions and methods for treating or ameliorating neuroinflammation, neurodegeneration, neuropathic pain, and migraine20 Dec 2018US 2018/0360993 A1The Regents of the University of California
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.